Practical and Scalable Manufacturing Process for Plasma Kallikrein Inhibitor ASP5069

The plasma kallikrein inhibitor ASP5069 is a promising drug candidate for the treatment of edema and hematoma and for the prevention of bleeding during surgery. Here, we report the development of a...